Hyperinsulinaemia in cancer

Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · see citing works

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works

Use and Abuse of HOMA Modeling

Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · see citing works

Body Fatness and Cancer — Viewpoint of the IARC Working Group

Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596 · see citing works

The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice

Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058 · see citing works

Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813904 · Cited by 2,622 · see citing works

Pathophysiology of human visceral obesity: an update

Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583 · see citing works

Metformin and reduced risk of cancer in diabetic patients

Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · see citing works

Insulin and insulin-like growth factor signalling in neoplasia

Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · see citing works

Insulin Receptor Signaling in Normal and Insulin-Resistant StatesPreprint

Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,475 · see citing works

Adipogenesis and metabolic health

Ghaben, A. L., & Scherer, P. E. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0093-z · Cited by 1,395 · see citing works

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

Thorpe, L. M., Yuzugullu, H., & Zhao, J. J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3860 · Cited by 1,365 · see citing works

Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease

Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126 · see citing works

Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk

Stern, J. H., Rutkowski, J. M., & Scherer, P. E. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.011 · Cited by 1,031 · see citing works

Ras in Cancer and Developmental Diseases

Fernández‐Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 959 · see citing works

Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets

Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885 · see citing works

Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study

Goodwin, P. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 867 · see citing works

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies

Tsilidis, K. K., Kasimis, J. C., López, D. S., Ntzani, E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 861 · see citing works

Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 852 · see citing works

Insulin Resistance and Hyperinsulinemia

Shanik, M. H., Xu, Y., Škrha, J., Dankner, R., Zick, Y., & Roth, J. (2008) · Diabetes Care · doi:10.2337/dc08-s264 · Cited by 791 · see citing works

Life without white fat: a transgenic mousePreprint

Moitra, J., Mason, M. M., Olive, M., Krylov, D. Y., Gavrilova, O., Marcus‐Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et al. (1998) · Genes & Development · doi:10.1101/gad.12.20.3168 · Cited by 776 · see citing works

Biochemical and cellular properties of insulin receptor signalling

Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739 · see citing works

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., et al. (2018) · Nature · doi:10.1038/s41586-018-0343-4 · Cited by 706 · see citing works

Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal women

Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640 · see citing works

Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy.

Raffaghello, L., Lee, C., Safdie, F. M., Wei, M., Madia, F., Bianchi, G., & Longo, V. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708100105 · Cited by 587 · see citing works

A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer

Tsuchida, T., Lee, Y. A., Fujiwara, N., Ybanez, M., Allen, B., Martins, S., Fiel, M. I., Goossens, N., Chou, H.-I., Hoshida, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.011 · Cited by 583 · see citing works

Sp1 and the ‘hallmarks of cancer’

Beishline, K., & Azizkhan‐Clifford, J. (2014) · FEBS Journal · doi:10.1111/febs.13148 · Cited by 528 · see citing works

Diabetes, pancreatogenic diabetes, and pancreatic cancer

Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516 · see citing works

40 YEARS OF IGF1: IGF1 receptor signaling pathways

Hakuno, F., & Takahashi, S. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0311 · Cited by 452 · see citing works

Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

Abdul‐Ghani, M. A., Norton, L., & DeFronzo, R. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0029 · Cited by 445 · see citing works

The effect of intermittent energy and carbohydrate restriction<i>v</i>. daily energy restriction on weight loss and metabolic disease risk markers in overweight women

Harvie, M., Wright, C., Pegington, M., McMullan, D., Mitchell, E., Martin, B., Cutler, R. G., Evans, G., Whiteside, S., Maudsley, S., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000792 · Cited by 431 · see citing works

Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

Law, J. H., Habibi, G., Hu, K., Masoudi, H., Wang, M. Y. C., Stratford, A. L., Park, E., Gee, J. M. W., Finlay, P., Jones, H. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2755 · Cited by 402 · see citing works

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Kordes, S., Pollak, M., Zwinderman, A. H., Mathôt, R. A. A., Weterman, M. J., Beeker, A., Punt, C. J. A., Richel, D. J., & Wilmink, J. W. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00027-3 · Cited by 387 · see citing works

Insulin Receptor Isoforms in Physiology and Disease: An Updated View

Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00073 · Cited by 376 · see citing works

Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes

Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes &amp; Development · doi:10.1101/gad.908001 · Cited by 369 · see citing works

Functionally distinct insulin receptors generated by tissue‐specific alternative splicing.

Mosthaf, L., Grako, K. A., Dull, T. J., Coussens, L. M., Ullrich, A., & McClain, D. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07416.x · Cited by 366 · see citing works

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Burtrum, D. B., Zhu, Z., Lu, D., Anderson, D. M., Prewett, M. C., PEREIRA, D. S., Bassi, R., Abdullah, R., Hooper, A. T., Koo, H., et al. (2003) · PubMed · Cited by 352 · see citing works

Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication

Funcke, J., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 337 · see citing works

Disrupting insulin-like growth factor signaling as a potential cancer therapy

Sachdev, D., & Yee, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0080 · Cited by 336 · see citing works

Functional expression of sodium-glucose transporters in cancer

Scafoglio, C., Hirayama, B. A., Kepe, V., Liu, J., Ghezzi, C., Satyamurthy, N., Moatamed, N. A., Huang, J., Koepsell, H., Barrio, J. R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511698112 · Cited by 331 · see citing works

A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men

Ma, J., Giovannucci, E. L., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh082 · Cited by 330 · see citing works

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Arteaga, C. L., Kitten, L. J., Coronado, E. B., Jacobs, S., Kull, F. C., Allred, D. C., & Osborne, C. K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114315 · Cited by 328 · see citing works

Repurposing metformin for cancer treatment: current clinical studies

Chae, Y. K., Arya, A., Malecek, M., Shin, D. S., Carneiro, B. A., Chandra, S., Kaplan, J. B., Kalyan, A., Altman, J. K., Platanias, L. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8194 · Cited by 325 · see citing works

Tissue-Specific Expression of Two Alternatively Spliced Insulin Receptor mRNAs in Man

Moller, D. E., Yokota, A., Caro, J. F., & Flier, J. S. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-8-1263 · Cited by 323 · see citing works

Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index

Lee, C. D., Safdie, F. M., Raffaghello, L., Wei, M., Madia, F., Parrella, E., Hwang, D., Cohen, P., Bianchi, G., & Longo, V. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3228 · Cited by 322 · see citing works

Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy

Sachdev, D., & Yee, D. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0080 · Cited by 315 · see citing works

Ethnic-Specific Criteria for Classification of Body Mass Index: A Perspective for Asian Indians and American Diabetes Association Position Statement

Misra, A. (2015) · Diabetes Technology &amp; Therapeutics · doi:10.1089/dia.2015.0007 · Cited by 292 · see citing works

Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes

Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A. M., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 281 · see citing works

Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting

BAILYES, E. M., NAVÉ, B. T., Soos, M. A., ORR, S. R., Hayward, A. C., & Siddle, K. (1997) · Biochemical Journal · doi:10.1042/bj3270209 · Cited by 278 · see citing works

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders

Madsen, R. R., Vanhaesebroeck, B., & Semple, R. K. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.08.003 · Cited by 276 · see citing works

The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study

Bauersfeld, S. P., Keßler, C. S., Wischnewsky, M. B., Jaensch, A., Steckhan, N., Stange, R., Kunz, B., Brückner, B., Sehouli, J., & Michalsen, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4353-2 · Cited by 260 · see citing works

The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

de Groot, S., Vreeswijk, M. P. G., Welters, M. J. P., Gravesteijn, G., Boei, J. J. W. A., Jochems, A., Houtsma, D., Putter, H., van der Hoeven, J. J. M., Nortier, J. W. R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1663-5 · Cited by 257 · see citing works

The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration

Villani, L. A., Smith, B. K., Marcinko, K., Ford, R. J., Broadfield, L. A., Green, A. E., Houde, V. P., Muti, P. C., Tsakiridis, T. K., & Steinberg, G. R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.08.014 · Cited by 246 · see citing works

Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes

Ugi, S., Imamura, T., Maegawa, H., Egawa, K., Yoshizaki, T., Shi, K., Obata, T., Ebina, Y., Kashiwagi, A., & Olefsky, J. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8778-8789.2004 · Cited by 241 · see citing works

Pancreatic β Cell Regeneration as a Possible Therapy for Diabetes

Aguayo‐Mazzucato, C., & Bonner‐Weir, S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.007 · Cited by 238 · see citing works

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

Ulanet, D. B., Ludwig, D. L., Kahn, C. R., & Hanahan, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914076107 · Cited by 235 · see citing works

The Splicing Factor RBM4 Controls Apoptosis, Proliferation, and Migration to Suppress Tumor Progression

Wang, Y., Chen, D., Qian, H., Tsai, Y., Shao, S., Liu, Q., Dominguez, D., & Wang, Z. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.010 · Cited by 224 · see citing works

Insulin receptor expression by human prostate cancers

Cox, M., Gleave, M. E., Zakikhani, M., Bell, R. H., Piura, E., Vickers, E., Cunningham, M., Larsson, O. S., Fazli, L., & Pollak, M. (2008) · The Prostate · doi:10.1002/pros.20852 · Cited by 224 · see citing works

Safety and feasibility of fasting in combination with platinum-based chemotherapy

Dorff, T. B., Groshen, S. G., García, A. A., Shah, M., Tsao-Wei, D. D., Pham, H. Q., Cheng, C., Brandhorst, S., Cohen, P., Wei, M., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2370-6 · Cited by 219 · see citing works

Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy

Safdie, F. M., Brandhorst, S., Wei, M., Wang, W., Lee, C. D., Hwang, S., Conti, P. S., Chen, T. C., & Longo, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044603 · Cited by 201 · see citing works

Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance

Camporez, J. P., Jornayvaz, F. R., Lee, H., Kanda, S., Guigni, B. A., Kahn, M., Samuel, V. T., Carvalho, C. R. D. O., Petersen, K. F., Jurczak, M. J., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1989 · Cited by 194 · see citing works

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

Sachdev, D., Li, S. L., Hartell, J. S., Fujita‐Yamaguchi, Y., Miller, J. S., & Yee, D. (2003) · PubMed · Cited by 190 · see citing works

Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition

Jenab, M., Ríboli, E., Cleveland, R. J., Norat, T., Rinaldi, S., Nieters, A., Biessy, C., Tjønneland, A. M., Olsen, A., Overvad, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22697 · Cited by 187 · see citing works

Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation

Farabaugh, S. M., Boone, D. N., & Lee, A. V. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00059 · Cited by 183 · see citing works

Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?

Yee, D. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs258 · Cited by 177 · see citing works

Are Metformin Doses Used in Murine Cancer Models Clinically Relevant

Chandel, N. S., Avizonis, D., Reczek, C. R., Weinberg, S. E., Menz, S., Neuhaus, R., Christian, S., Haegebarth, A., Algire, C., & Pollak, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.010 · Cited by 176 · see citing works

Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth

Xia, S., Lin, R., Jin, L., Zhao, L., Kang, H., Pan, Y., Liu, S., Qian, G., Qian, Z., Konstantakou, E., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.010 · Cited by 171 · see citing works

Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer

Okumura, S., Kaido, T., Hamaguchi, Y., Kobayashi, A., Shirai, H., Yao, S., Yagi, S., Kamo, N., Hatano, E., Okajima, H., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6077-y · Cited by 169 · see citing works

Insulin resistance and body composition in cancer patients

Dev, R., Bruera, E. D., & Dalal, S. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx815 · Cited by 167 · see citing works

The insulin receptor: a prototype for dimeric, allosteric membrane receptors?

MEYTS, P. D. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.06.003 · Cited by 162 · see citing works

Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression

Hancock, M., Meyer, R. C., Mistry, M., Khetani, R. S., Wagschal, A., Shin, T., Sui, S. J. H., Näär, A. M., & Flanagan, J. G. (2019) · Cell · doi:10.1016/j.cell.2019.02.030 · Cited by 159 · see citing works

Preventable Cancer Burden Associated With Poor Diet in the United States

Zhang, F. F., Cudhea, F., Shan, Z., Michaud, D. S., Imamura, F., Eom, H., Ruan, M., Rehm, C. D., Liu, J., Du, M., et al. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz034 · Cited by 159 · see citing works

β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity

Mezza, T., Cinti, F., CEFALO, C. M. A., Pontecorvi, A., Kulkarni, R., & Giaccari, A. (2019) · Diabetes · doi:10.2337/db18-0856 · Cited by 154 · see citing works

Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones

Yakar, S., Núñez, N. P., Pennisi, P. A., Brodt, P., Sun, H., Fallavollita, L., Zhao, H., Scavo, L. M., Novosyadlyy, R., Kurshan, N., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0311 · Cited by 152 · see citing works

Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study

Yuan, S., Kar, S., Carter, P., Vithayathil, M. K., Mason, A. M., Burgess, S., & Larsson, S. C. (2020) · Diabetes · doi:10.2337/db20-0084 · Cited by 150 · see citing works

Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.

Webster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 150 · see citing works

Hormonal, Metabolic, and Inflammatory Profiles and Endometrial Cancer Risk Within the EPIC Cohort—A Factor Analysis

Dossus, L., Lukanova, A., Rinaldi, S., Allen, N. E., Cust, A. E., Becker, S., Tjønneland, A. M., Hansen, L., Overvad, K., Chabbert‐Buffet, N., et al. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws309 · Cited by 148 · see citing works

Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice

Chang, H.-H., Moro, A., Takakura, K., Su, H., Mo, A., Nakanishi, M., Waldron, R. T., French, S. W., Dawson, D. W., Hines, O. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184455 · Cited by 144 · see citing works

The broken “Off” switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance

Ruvolo, P. P. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.08.002 · Cited by 143 · see citing works

Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study

Irwin, M. L., Duggan, C. R., Wang, C., Smith, A. W., McTiernan, A., Baumgartner, R., Baumgartner, K. B., Bernstein, L., & Ballard-Barbash, R. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4752 · Cited by 142 · see citing works

Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation

Klement, R. J. (2017) · Medical Oncology · doi:10.1007/s12032-017-0991-5 · Cited by 140 · see citing works

Proinsulin and C-peptide: A review

Kitabchi, A. E. (1977) · Metabolism · doi:10.1016/0026-0495(77)90099-3 · Cited by 140 · see citing works

Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population‐based observational study

Tsujimoto, T., Kajio, H., & Sugiyama, T. (2017) · International Journal of Cancer · doi:10.1002/ijc.30729 · Cited by 134 · see citing works

Chronic Hyperglycemia Predisposes to Exaggerated Inflammatory Response and Leukocyte Dysfunction in Akita Mice

Gyurko, R., Siqueira, C. C., Caldon, N., Gao, L., Kantarcı, A., & Dyke, T. E. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7250 · Cited by 132 · see citing works

Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors

Chettouh, H., Fartoux, L., Aoudjehane, L., Wendum, D., Clapéron, A., Chrétien, Y., Rey, C., Scatton, O., Soubrane, O., Conti, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3824 · Cited by 131 · see citing works

Breast Cancer Risk in Metabolically Healthy but Overweight Postmenopausal Women

Gunter, M. J., Xie, X., Xue, X., Kabat, G. C., Rohan, T. E., Wassertheil-Smoller, S. W., Ho, G., Wylie‐Rosett, J., Greco, T., Yu, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2317 · Cited by 131 · see citing works

Effects of short-term fasting on cancer treatment

de Groot, S., Pijl, H., van der Hoeven, J. J. M., & Kroep, J. R. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1189-9 · Cited by 129 · see citing works

Deletion of serine/arginine‐rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice

Sen, S., Langiewicz, M., Jumaa, H., & Webster, N. J. G. (2014) · Hepatology · doi:10.1002/hep.27380 · Cited by 127 · see citing works

Standardization of Negative Controls in Diagnostic Immunohistochemistry

Torlakovic, E., Francis, G. D., Garratt, J., Gilks, C. B., Hyjek, E. M., Ibrahim, M., Miller, R. T., Nielsen, S. M., Petcu, E. B., Swanson, P. E., et al. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000069 · Cited by 124 · see citing works

Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents

Tricò, D., Natali, A., Arslanian, S. A., Mari, A., & Ferrannini, E. (2018) · JCI Insight · doi:10.1172/jci.insight.124912 · Cited by 121 · see citing works

Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival

Zheng, Q., Dunlap, S. M., Zhu, J., Downs-Kelly, E. P., Rich, J. N., Hursting, S. D., Berger, N. A., & Reizes, O. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0102 · Cited by 120 · see citing works

A Western-Type Diet Accelerates Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer

Llaverı́as, G., Danilo, C., Wang, Y., Witkiewicz, A. K., Daumer, K. M., Lisanti, M. P., & Frank, P. G. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100568 · Cited by 119 · see citing works

Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation

Zhang, H., Fagan, D. H., Zeng, X., Freeman, K. T., Sachdev, D., & Yee, D. (2010) · Oncogene · doi:10.1038/onc.2010.17 · Cited by 118 · see citing works

HMGA1 in cancer: Cancer classification by location

Wang, Y., Hu, L. T., Zheng, Y., & Guo, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14082 · Cited by 118 · see citing works

Regulation of IGF -1 signaling by microRNAs

Jung, H. J., & Suh, Y. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2014.00472 · Cited by 117 · see citing works

SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia

Nasiri, A. R., Rodrigues, M. R. D. S., Li, Z., Leitner, B. P., & Perry, R. J. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0203-1 · Cited by 116 · see citing works

SRp20 and CUG-BP1 Modulate Insulin Receptor Exon 11 Alternative Splicing

Sen, S., Talukdar, I., & Webster, N. J. G. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01709-08 · Cited by 114 · see citing works

Modeling the Western Diet for Preclinical Investigations

Hintze, K. J., Benninghoff, A. D., Cho, C. E., & Ward, R. E. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy002 · Cited by 112 · see citing works

The Obesity-Cancer Link: Lessons Learned from a Fatless Mouse

Hursting, S. D., Nunez, N. P., Varticovski, L., & Vinson, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4237 · Cited by 110 · see citing works

A brief perspective on insulin production

Steiner, D. F., Park, S., Støy, J., Philipson, L. H., & Bell, G. I. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01106.x · Cited by 109 · see citing works

Childhood obesity: Aetiology, comorbidities, and treatment

Camacho, W. J. M., Díaz, J. M. M., Ortiz, S. P., Ortiz, J. E. P., Camacho, M. A. M., & Calderón, B. P. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3203 · Cited by 107 · see citing works

Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women

Michaud, D. S., Wolpin, B. M., Giovannucci, E. L., Liu, S., Cochrane, B. B., Manson, J. E., Pollak, M., Ma, J., & Fuchs, C. S. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0182 · Cited by 103 · see citing works

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

MYME investigators, Nanni, O., Amadori, D., DeCensi, A., Rocca, A., Freschi, A., Bologna, A., Gianni, L., Rosetti, F., Amaducci, L., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05070-2 · Cited by 102 · see citing works

Hyperinsulinemia Predicts Fatal Liver Cancer but Is Inversely Associated With Fatal Cancer at Some Other Sites

Balkau, B., Kahn, H. S., Courbon, D., Eschwège, É., & Ducimetière, P. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.843 · Cited by 101 · see citing works

Proinsulin Binds with High Affinity the Insulin Receptor Isoform A and Predominantly Activates the Mitogenic Pathway

Malaguarnera, R., Sacco, A., Voci, C., Pandini, G., Vigneri, R., & Belfiore, A. (2012) · Endocrinology · doi:10.1210/en.2011-1843 · Cited by 100 · see citing works

A Review on the Relationship between SGLT2 Inhibitors and Cancer

Lin, H.-W., & Tseng, C. (2014) · International Journal of Endocrinology · doi:10.1155/2014/719578 · Cited by 99 · see citing works

Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes

Ferguson, R. D., Novosyadlyy, R., Fierz, Y., Alikhani, N., Sun, H., Yakar, S., & LeRoith, D. (2012) · Breast Cancer Research · doi:10.1186/bcr3089 · Cited by 97 · see citing works

Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations—Role of Carbohydrate and Energy Availability

Bojsen-Møller, K. N., Lundsgaard, A., Madsbad, S., Kiens, B., & Holst, J. J. (2018) · Diabetes · doi:10.2337/db18-0539 · Cited by 97 · see citing works

Obesity promotes melanoma tumor growth: Role of leptin

Brandon, E. L., Gu, J.-W., Cantwell, L. M., He, Z., Wallace, G., & Hall, J. E. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.19.9650 · Cited by 97 · see citing works

Endogenous Hyperinsulinemia Contributes to Pancreatic Cancer Development

Zhang, A. M. Y., Magrill, J., de Winter, T. J. J., Hu, X., Skovsø, S., Schaeffer, D. F., Kopp, J. L., & Johnson, J. D. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.003 · Cited by 97 · see citing works

Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer

Mulligan, A. M., O’Malley, F. P., Ennis, M., Fantus, I. G., & Goodwin, P. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9471-x · Cited by 96 · see citing works

A Nested Case–Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Murphy, N., Cross, A. J., Abubakar, M., Jenab, M., Aleksandrova, K., Boutron‐Ruault, M., Dossus, L., Racine, A., Kuhn, T. E., Katzke, V. A., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1001988 · Cited by 93 · see citing works

Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression

Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 92 · see citing works

p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas

Hsieh, M.-H., Choe, J. H., Gadhvi, J. G., Kim, Y. J., Arguez, M. A., Palmer, M., Gerold, H., Nowak, C. M., Do, H., Mazambani, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.027 · Cited by 92 · see citing works

Minireview: Were the IGF Signaling Inhibitors All Bad?

Beckwith, H. C., & Yee, D. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1157 · Cited by 91 · see citing works

Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia

Gallagher, E. J., Fierz, Y., Vijayakumar, A., Haddad, N., Yakar, S., & LeRoith, D. (2011) · Oncogene · doi:10.1038/onc.2011.495 · Cited by 85 · see citing works

The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action

Werner, H., & Maor, S. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.06.007 · Cited by 83 · see citing works

Nova1 is a master regulator of alternative splicing in pancreatic beta cells

Villate, O., Turatsinze, J., Mascali, L. G., Grieco, F. A., Nogueira, T. C., Cunha, D. A., Nardelli, T. R., Sammeth, M., Salunkhe, V. A., Esguerra, J. L. S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku861 · Cited by 82 · see citing works

Muscleblind-like 1 (Mbnl1) Promotes Insulin Receptor Exon 11 Inclusion via Binding to a Downstream Evolutionarily Conserved Intronic Enhancer

Sen, S., Talukdar, I., Liu, Y. M., Tam, J. W. O., Reddy, S., & Webster, N. J. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095224 · Cited by 82 · see citing works

The multifaceted effects of metformin on tumor microenvironment

Kurelac, I., Ganesh, N. U., Iorio, M. C., Porcelli, A. M., & Gasparre, G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.010 · Cited by 81 · see citing works

High-fat Western diet–induced obesity contributes to increased tumor growth in mouse models of human colon cancer

O’Neill, A. M., Burrington, C. M., Gillaspie, E. A., Lynch, D. T., Horsman, M. J., & Greene, M. W. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.10.005 · Cited by 73 · see citing works

Highly specific role of the insulin receptor in breast cancer progression

Rostoker, R., Abelson, S., Bitton-Worms, K., Genkin, I., Ben-Shmuel, S., Dakwar, M., Orr, Z. S., Caspi, A., Tzukerman, M., & LeRoith, D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0490 · Cited by 72 · see citing works

hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene

Talukdar, I., Sen, S., Urbano, R., Thompson, J. X., Yates, J. R., & Webster, N. J. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027869 · Cited by 71 · see citing works

The insulin receptor translocates to the nucleus to regulate cell proliferation in liver

Amaya, M. J., de Oliveira, A. G., Guimarães, E. S., Casteluber, M. C. D. F., Carvalho, S. M., de Andrade, L. M., Pinto, M. C. X., Mennone, A., Oliveira, C. A., Resende, R. R., et al. (2013) · Hepatology · doi:10.1002/hep.26609 · Cited by 71 · see citing works

Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes

Wu, A., Chen, J., & Baserga, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210636 · Cited by 70 · see citing works

Role of Insulin Receptor in the Regulation of Glucose Uptake in Neonatal Hepatocytes

Nevado, C., Valverde, Á. M., & Benito, M. (2006) · Endocrinology · doi:10.1210/en.2005-1663 · Cited by 67 · see citing works

Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage

Aleksic, T., Gray, N., Wu, X., Rieunier, G., Osher, E. L., Mills, J. V., Verrill, C. L., Bryant, R. J., Han, C., Hutchinson, K., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3498 · Cited by 67 · see citing works

Structural Dynamics of Insulin Receptor and Transmembrane Signaling

Tatulian, S. A. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00805 · Cited by 64 · see citing works

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin

Slaaby, R. (2015) · Scientific Reports · doi:10.1038/srep07911 · Cited by 63 · see citing works

Quantifying Mediating Effects of Endogenous Estrogen and Insulin in the Relation between Obesity, Alcohol Consumption, and Breast Cancer

Hvidtfeldt, U. A., Gunter, M. J., Lange, T., Chlebowski, R. T., Lane, D. S., Farhat, G. N., Freiberg, M. S., Keiding, N., Lee, J. S., Prentice, R. L., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0310 · Cited by 63 · see citing works

Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus

Reilly, T. P., Graziano, M. J., Janovitz, E. B., Dorr, T. E., Fairchild, C. R., Lee, F. Y., Chen, J., Wong, T., Whaley, J. M., & Tirmenstein, M. A. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0053-3 · Cited by 63 · see citing works

Expression and function of the insulin‐like growth factor I system in human non‐small‐cell lung cancer and normal lung cell lines

Favoni, R. E., de Cupis, A., Ravera, F., Cantoni, C., Pirani, P., Ardizzoni, A., Noonan, D. M., & Biassoni, R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560618 · Cited by 63 · see citing works

Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer

Kim, J., Kim, E. S., Liu, D., Lee, J. J., Solis, L. M., Behrens, C., Lippman, S. M., Hong, W. K., Wistuba, I. I., & Lee, H. (2011) · Cancer · doi:10.1002/cncr.26492 · Cited by 62 · see citing works

Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats

Dombrowski, F., Mathieu, C., & Evert, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2787 · Cited by 61 · see citing works

Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer

Blanquart, C., Achi, J., & Issad, T. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.027 · Cited by 59 · see citing works

Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis

Liśkiewicz, A., Liśkiewicz, D., Wojakowska, A., Polański, K., Lewin‐Kowalik, J., Kotulska, K., & Jędrzejowska–Szypułka, H. (2016) · Scientific Reports · doi:10.1038/srep21807 · Cited by 58 · see citing works

Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer

Wang, Y., Nasiri, A. R., Damsky, W., Perry, C. J., Zhang, X., Rabin-Court, A., Pollak, M., Shulman, G. I., & Perry, R. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.008 · Cited by 57 · see citing works

Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and -2 Are Differentially Expressed in Prostate Cancer

Heni, M., Hennenlotter, J., Scharpf, M. O., Lutz, S. Z., Schwentner, C., Todenhöfer, T., Schilling, D., Kühs, U., Gerber, V., Machicao, F. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050953 · Cited by 57 · see citing works

Adipose tissue insulin resistance due to loss of PI3K p110α leads to decreased energy expenditure and obesity

Nelson, V. L., Jiang, Y., Dickman, K. G., Ballou, L. M., & Lin, R. Z. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00625.2013 · Cited by 56 · see citing works

Ablation of PI3K p110-α Prevents High-Fat Diet–Induced Liver Steatosis

Chattopadhyay, M., Selinger, E. S., Ballou, L. M., & Lin, R. Z. (2011) · Diabetes · doi:10.2337/db10-0869 · Cited by 56 · see citing works

Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence.

Harvie, M., & Howell, T. (2016) · Advances in Nutrition · doi:10.3945/an.115.011767 · Cited by 56 · see citing works

Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease

Ahearn, T. U., Peisch, S. F., Pettersson, A., Ebot, E. M., Zhou, C. K., Graff, R. E., Sinnott, J. A., Fazli, L., Judson, G. L., Bismar, T. A., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy112 · Cited by 56 · see citing works

The effect of dietary fat and carbohydrate on diethylstilbestrol-induced mammary cancer in rats.

Dunning, W. F., Curtis, M. R., & Maun, M. E. (1949) · PubMed · Cited by 54 · see citing works

Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin

Jonghe, S. D., Proctor, J., Vinken, P., Feyen, B., Wynant, I., Mariën, D., Geys, H., Mamidi, R. N. V. S., & Johnson, M. D. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.09.018 · Cited by 53 · see citing works

Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model.

Pour, P. M., & Kazakoff, K. R. (1996) · PubMed · Cited by 52 · see citing works

Plasma insulin, C ‐peptide and blood glucose and the risk of gastric cancer: The J apan P ublic H ealth C enter‐based prospective study

Hidaka, A., Sasazuki, S., Goto, A., Sawada, N., Shimazu, T., Yamaji, T., Iwasaki, M., Inoue, M., Noda, M., Tajiri, H., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29098 · Cited by 52 · see citing works

High-fat Diet Enhances Mammary Tumorigenesis and Pulmonary Metastasis and Alters Inflammatory and Angiogenic Profiles in MMTV-PyMT Mice

Sundaram, S., & Yan, L. (2016) · Anticancer Research · doi:10.21873/anticanres.11223 · Cited by 52 · see citing works

Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer

Ferguson, R. D., Gallagher, E. J., Cohen, D., Tobin‐Hess, A., Alikhani, N., Novosyadlyy, R., Haddad, N., Yakar, S., & LeRoith, D. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0333 · Cited by 51 · see citing works

IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer

Aleksic, T., Verrill, C. L., Bryant, R. J., Han, C., Worrall, A. R., Brureau, L., Larré, S., Higgins, G. S., Fazal, F., Sabbagh, A. A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.337 · Cited by 51 · see citing works

EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature

McDonald, T. J., Perry, M. H., Peake, R. W. A., Pullan, N. J., O’Connor, J., Shields, B. M., Knight, B. A., & Hattersley, A. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042084 · Cited by 49 · see citing works

Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women’s Health Initiative

Pan, K., Nelson, R. A., Wactawski‐Wende, J., Lee, D. J., Manson, J. E., Aragaki, A. K., Mortimer, J. E., Phillips, L. S., Rohan, T. E., Ho, G. Y. F., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz069 · Cited by 48 · see citing works

Quantifying insulin receptor isoform expression in FFPE breast tumors

Harrington, S. C., Weroha, S. J., Reynolds, C. A., Suman, V. J., Lingle, W. L., & Haluska, P. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.04.001 · Cited by 48 · see citing works

Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers

Farrington, C. C., Yuan, E., Mazhar, S., Izadmehr, S., Hurst, L., Allen-Petersen, B. L., Janghorban, M., Chung, E. M., Wolczanski, G., Galsky, M. D., et al. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49933-9 · Cited by 47 · see citing works

Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes

Loftfield, E., Freedman, N. D., Lai, G. Y., Weinstein, S. J., McGlynn, K. A., Taylor, P. R., Männistö, S., Albanes, D., & Stolzenberg‐Solomon, R. Z. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0141 · Cited by 45 · see citing works

RBM4 Promotes Pancreas Cell Differentiation and Insulin Expression

Lin, J.-C., Yan, Y., Hsieh, W.-K., Peng, P.-J., Su, C.-H., & Tarn, W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01266-12 · Cited by 45 · see citing works

Prostate cancer cell proliferation and angiogenesis in different obese mice models

Ribeiro, A. M., Andrade, S., Pinho, F., Monteiro, J. D., Costa, M. M., Lopes, C., Águas, A. P., & Monteiro, M. P. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00726.x · Cited by 45 · see citing works

Receptor-isoform-selective insulin analogues give tissue-preferential effects

Vienberg, S. G., Bouman, S. D., Sørensen, H., Stidsen, C. E., Kjeldsen, T., Glendorf, T., Sørensen, A. R., Olsen, G. S., Andersen, B., & Nishimura, E. (2011) · Biochemical Journal · doi:10.1042/bj20110880 · Cited by 44 · see citing works

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas

Cheson, B. D., O'Brien, S. M., Ewer, M. S., Goncalves, M. D., Farooki, A., Lenz, G., Yu, A. F., Fisher, R. I., Zinzani, P. L., & Dreyling, M. H. (2018) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2018.11.021 · Cited by 44 · see citing works

SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome

Liu, B. A., Engelmann, B. W., Jablonowski, K. D., Higginbotham, K., Stergachis, A. B., & Nash, P. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-27 · Cited by 43 · see citing works

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer

Senapati, P., Kato, H., Lee, M., Leung, A., Thai, C., Sanchez, A., Gallagher, E. J., LeRoith, D., Seewaldt, V. L., Ann, D. K., et al. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0290-9 · Cited by 42 · see citing works

Toward a cancer-specific diet

Bozzetti, F., & Zupec‐Kania, B. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.01.013 · Cited by 40 · see citing works

Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes

Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0091 · Cited by 39 · see citing works

Associations of Serum Isoflavone, Adiponectin and Insulin Levels with Risk for Epithelial Ovarian Cancer: Results of a Case-control Study

Otokozawa, S., Tanaka, R., Akasaka, H., Ito, E., Asakura, S., Ohnishi, H., Saito, S., Miura, T., Saito, T., & Mori, M. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.12.4987 · Cited by 39 · see citing works

Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.

Pfützner, A., Kann, P. H., Pfützner, A. H., Kunt, T., Larbig, M., Weber, M. M., & Forst, T. M. (2004) · PubMed · Cited by 39 · see citing works

Experimental Animal Models of Pancreatic Carcinogenesis for Prevention Studies and Their Relevance to Human Disease

Takahashi, M., Hori, M., Mutoh, M., Wakabayashi, K., & Nakagama, H. (2011) · Cancers · doi:10.3390/cancers3010582 · Cited by 38 · see citing works

Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers

Farrington, C. C., Yuan, E., Mazhar, S., Izadmehr, S., Hurst, L., Allen-Petersen, B. L., Janghorban, M., Chung, E. M., Wolczanski, G., Galsky, M. D., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011443 · Cited by 38 · see citing works

HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene

Aiello, A., Pandini, G., Sarfstein, R., Werner, H., Manfioletti, G., Vigneri, R., & Belfiore, A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.050 · Cited by 37 · see citing works

Insulin‐independent promotion of chemically induced hepatocellular tumor development in genetically diabetic mice

Yamasaki, K., Hayashi, Y., Okamoto, S., Osanai, M., & Lee, G. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01345.x · Cited by 36 · see citing works

Metabolic insights from extreme human insulin resistance phenotypes

Stears, A. J., O’Rahilly, S., Semple, R. K., & Savage, D. B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.003 · Cited by 36 · see citing works

Nonclinical Safety of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin

Bogdanffy, M. S., Stachlewitz, R. F., van Tongeren, S., Knight, B., Sharp, D. E., Ku, W. W., Hart, S. E., & Blanchard, K. T. (2014) · International Journal of Toxicology · doi:10.1177/1091581814551648 · Cited by 35 · see citing works

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma

Jiang, L., Zhu, W., Streicher, K. L., Morehouse, C., Brohawn, P. Z., Ge, X., Dong, Z., Yin, X., Zhu, G., Gu, Y., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-131 · Cited by 34 · see citing works

Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2

Sarkar, P. L., Lee, W., Williams, E. D., Lubik, A. A., Stylianou, N., Shokoohmand, A., Lehman, M., Hollier, B. G., Gunter, J. H., & Nelson, C. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00481 · Cited by 33 · see citing works

The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia

Sheth, K., & Cheson, B. D. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620715625966 · Cited by 33 · see citing works

Regulation of Breast Cancer Metastasis by IGF Signaling

Sachdev, D. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9105-5 · Cited by 32 · see citing works

Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model

Tessitore, A., Mastroiaco, V., Vetuschi, A., Sferra, R., Pompili, S., Cicciarelli, G., Barnabei, R., Capece, D., Zazzeroni, F., Capalbo, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18585 · Cited by 32 · see citing works

Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor

Forest, A., Amatulli, M., Ludwig, D. L., Damoci, C. B., Wang, Y., Burns, C. A., Donoho, G. P., Zanella, N., Fiebig, H., Prewett, M. C., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0279 · Cited by 30 · see citing works

EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice

Zelenko, Z., Gallagher, E. J., Antoniou, I. M., Sachdev, D., Nayak, A., Yee, D., & LeRoith, D. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0142 · Cited by 30 · see citing works

Role of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism

Li, M. E., Lauritzen, H. P. M. M., O'Neill, B. T., Wang, C., Cai, W., Brandão, B. B., Sakaguchi, M., Tao, R., Hirshman, M. F., Softic, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11265-y · Cited by 29 · see citing works

Investigating New Therapeutic Strategies Targeting Hyperinsulinemia's Mitogenic Effects in a Female Mouse Breast Cancer Model

Rostoker, R., Bitton-Worms, K., Caspi, A., Shen‐Orr, Z., & LeRoith, D. (2013) · Endocrinology · doi:10.1210/en.2012-2263 · Cited by 29 · see citing works

Importance of diabetes in inhibition of pancreatic cancer by streptozotocin

Bell, R. H., Sayers, H. J., Pour, P. M., Ray, M. B., & McCullough, P. J. (1989) · Journal of Surgical Research · doi:10.1016/0022-4804(89)90170-4 · Cited by 29 · see citing works

Abdominal adipocyte populations in women with visceral obesity

Michaud, A., Laforest, S., Pelletier, M., Nadeau, M., Simard, S., Daris, M., Lebœuf, M., Vidal, H., Géloën, A., & Tchernof, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0822 · Cited by 28 · see citing works

Diabetes, Metformin, and Breast Cancer: Lilac Time?

Goodwin, P. J., Thompson, A. M., & Stambolic, V. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.3319 · Cited by 26 · see citing works

Pancreatic carcinogenicity of N-nitrosobis(2-oxopropyl)-amine in diabetic and non-diabetic Chinese hamsters

Bell, R. H., & Pour, P. M. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90014-0 · Cited by 26 · see citing works

Comparison of solubilized and purified plasma membrane and nuclear insulin receptors

Wong, K., Hawley, D. M., Vigneri, R., & Goldfine, I. D. (1988) · Biochemistry · doi:10.1021/bi00401a056 · Cited by 20 · see citing works

Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model

Arcidiacono, D., Dedja, A., Giacometti, C., Fassan, M., Nucci, D., Francia, S., Fabris, F., Zaramella, A., Gallagher, E. J., Cassaro, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041198 · Cited by 19 · see citing works

OP449 inhibits breast cancer growth without adverse metabolic effects

Shlomai, G., Zelenko, Z., Antoniou, I. M., Stasinopoulos, M., Tobin‐Hess, A., Vitek, M. P., LeRoith, D., & Gallagher, E. J. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0077 · Cited by 16 · see citing works

Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice

Ben-Shmuel, S., Scheinman, E. J., Rashed, R., Orr, Z. S., Gallagher, E. J., LeRoith, D., & Rostoker, R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0310 · Cited by 14 · see citing works

Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis

Lkhagvadorj, S., Oh, S., Lee, M.-R., Jung, J. H., Chung, H. C., Cha, S., & Eom, M. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.4.861 · Cited by 14 · see citing works

Insulin Receptor at the Mouse Hepatocyte Nucleus after a Glucose Meal Induces Dephosphorylation of a 30-kDa Transcription Factor and a Concomitant Increase in Malic Enzyme Gene Expression

Gletsu-Miller, N. A., Dixon, W. T., & Clandinin, M. T. (1999) · Journal of Nutrition · doi:10.1093/jn/129.12.2154 · Cited by 14 · see citing works

Inverse relationship between insulin receptor expression and progression in renal cell carcinoma

Takahashi, M., Inoue, T., Huang, M., Numakura, K., Tsuruta, H., Saito, M., Maeno, A., Nakamura, E., Narita, S., Tsuchiya, N., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5552 · Cited by 13 · see citing works

Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon

Santoro, M. A., Blue, R. E., Andres, S. F., Mah, A. T., Landeghem, L. V., & Lund, P. K. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00189.2015 · Cited by 12 · see citing works

Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study

Walraven, I., Riet, E. V. ‘., Stehouwer, C. D. A., Polak, B. C. P., Moll, A. C., Dekker, J. M., & Nijpels, G. (2013) · Diabetologia · doi:10.1007/s00125-013-2864-6 · Cited by 12 · see citing works

Interplay of Liver Disease and Gut Microbiota in the Development of Colorectal Neoplasia

Gleeson, M. W. (2019) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-019-00241-6 · Cited by 6 · see citing works

Molecular and cellular mechanisms governing the ligand-specific and non-specific steps of insulin receptor internalization.

Jl, C., Hamer, I., Gilbert, A., & Paccaud, J. P. (1996) · PubMed · Cited by 4 · see citing works

Definition and diagnostic criteria of clinical obesity

Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes &amp; Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811 · see citing works

Metabolomics in cancer research and emerging applications in clinical oncology

Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 652 · see citing works

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 439 · see citing works

Tumour fatty acid metabolism in the context of therapy resistance and obesity

Hoy, A. J., Nagarajan, S. R., & Butler, L. M. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00388-4 · Cited by 408 · see citing works

Hyperinsulinemia in Obesity, Inflammation, and Cancer

Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 320 · see citing works

Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer

Janssen, J. A. M. J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157797 · Cited by 296 · see citing works

Obesity, Type 2 Diabetes, and Cancer Risk

Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 269 · see citing works

Adipokines: masterminds of metabolic inflammation

Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 219 · see citing works

Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications

Schulze, M. B., & Stefan, N. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01008-5 · Cited by 184 · see citing works

Insulin Resistance and Cancer: In Search for a Causal Link

CHIEFARI, E. D., Mirabelli, M., Vignera, S. L., Tanyolaç, S., FOTI, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 175 · see citing works

Developing dietary interventions as therapy for cancer

Taylor, S. R., Falcone, J. N., Cantley, L. C., & Goncalves, M. D. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00485-y · Cited by 160 · see citing works

An overview of cancer health disparities: new approaches and insights and why they matter

Minas, T. Z., Bailey‐Whyte, M., Ajao, A., & Ambs, S. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa121 · Cited by 117 · see citing works

Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains

Nagao, H., Cai, W., Albrechtsen, N. J. W., Steger, M., Batista, T. M., Pan, H., Dreyfuss, J. M., Mann, M., & Kahn, C. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019474118 · Cited by 113 · see citing works

Metabolic dysfunction-associated steatotic liver disease and its link to cancer

Kalligeros, M., Henry, L. L., & Younossi, Z. M. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156004 · Cited by 113 · see citing works

Insulin Resistance: The Increased Risk of Cancers

Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 107 · see citing works

Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis

Murphy, N., Song, M., Papadimitriou, N., Carreras‐Torres, R., Langenberg, C., Martin, R. M., Tsilidis, K. K., Barroso, I., Chen, J., Frayling, T. M., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac011 · Cited by 98 · see citing works

Regulation and function of insulin and insulin-like growth factor receptor signalling

Choi, E., Duan, C., & Bai, X. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00826-3 · Cited by 94 · see citing works

Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation

Zhang, A. M. Y., Xia, Y. H., Lin, J. S. H., Chu, K., Wang, W. C. K., Ruiter, T. J. J., Yang, J. C. C., Chen, N., Chhuor, J., Patil, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.003 · Cited by 91 · see citing works

Insulin and cancer: a tangled web

Leitner, B. P., Siebel, S., Akingbesote, N. D., Zhang, X., & Perry, R. J. (2022) · Biochemical Journal · doi:10.1042/bcj20210134 · Cited by 76 · see citing works

Obesity: a perfect storm for carcinogenesis

Harris, B. H. L., Macaulay, V. M., Harris, D. A., Klenerman, P., Karpe, F., Lord, S., Harris, A. L., & Buffa, F. M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10046-2 · Cited by 80 · see citing works

Cellular mechanisms linking cancers to obesity

Liu, X., Pedersen, L., & Halberg, N. (2021) · Cell Stress · doi:10.15698/cst2021.05.248 · Cited by 72 · see citing works

Diversity of insulin and IGF signaling in breast cancer: Implications for therapy

Lero, M. W., & Shaw, L. M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111213 · Cited by 70 · see citing works

Value of C-Reactive Protein-Triglyceride Glucose Index in Predicting Cancer Mortality in the General Population: Results from National Health and Nutrition Examination Survey

Zhao, D. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2273577 · Cited by 68 · see citing works

Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation

Naaman, S., Shen, S., Zeytinoglu, M., & Iyengar, N. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac241 · Cited by 66 · see citing works

Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study

Bea, S., Son, H., Bae, J. H., Cho, S. W., Shin, J., & Cho, Y. M. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15292 · Cited by 64 · see citing works

Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes

Cho, H., Lai, C.-C., Bonnavion, R., Alnouri, M. W., Wang, S., Roquid, K. A., Kawase, H., Campos, D., Chen, M., Weinstein, L. S., et al. (2025) · Science · doi:10.1126/science.adr4731 · Cited by 63 · see citing works

Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism

Lee‐Rueckert, M., Canyelles, M., Tondo, M., Rotllán, N., Kovanen, P. T., Llorente‐Cortés, V., & Escolá‐Gil, J. C. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.05.002 · Cited by 68 · see citing works

Fructose‐1,6‐Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis

Liu, G., Wang, N., Zhang, C., Li, M., He, X., Yin, C., Tu, Q., Shen, X., Zhang, L., Lv, J., et al. (2021) · Hepatology · doi:10.1002/hep.32064 · Cited by 61 · see citing works

Changes in Cells Associated with Insulin Resistance

Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042397 · Cited by 74 · see citing works

Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions

Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61 · see citing works

Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective

Tanabe, H., Masuzaki, H., & Shimabukuro, M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109067 · Cited by 59 · see citing works

Metabolic dependencies and targets in ovarian cancer

Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 59 · see citing works

Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis

Shen, X., Wang, Y., Zhao, R., Wan, Q., Wu, Y., Zhao, L., & Wu, X. (2021) · International Journal of Colorectal Disease · doi:10.1007/s00384-021-03974-y · Cited by 56 · see citing works

The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature

Tseng, C. (2021) · Biomolecules · doi:10.3390/biom11071022 · Cited by 54 · see citing works

Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet

Zhao, S., Peralta, R. M., Avina-Ochoa, N., Delgoffe, G. M., & Kaech, S. M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101485 · Cited by 57 · see citing works

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status

Hu, C., Chen, Y., Yin, X., Xu, R., Yin, C., Wang, C., & Zhao, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02098-3 · Cited by 59 · see citing works

Molecular mechanisms of action of metformin: latest advances and therapeutic implications

Zhu, H., Jia, Z., Li, Y. R., & Danelisen, I. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01051-y · Cited by 57 · see citing works

Pathogenesis of (smoking-related) non-communicable diseases—Evidence for a common underlying pathophysiological pattern

Kopp, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1037750 · Cited by 55 · see citing works

A stepwise activation model for the insulin receptor

Yunn, N.-O., Kim, J., Ryu, S. H., & Cho, Y. (2023) · Experimental and Molecular Medicine · doi:10.1038/s12276-023-01101-1 · Cited by 49 · see citing works

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors

Dąbrowski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041680 · Cited by 47 · see citing works

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

Liu, D., Weintraub, M. A., Garcia, C., Goncalves, M. D., Sisk, A. E., Casas, A., Harding, J. J., Harnicar, S. J., Drilon, A. E. D. C., Jhaveri, K. L., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4579 · Cited by 47 · see citing works

Critical material designs for mucus- and mucosa-penetrating oral insulin nanoparticle development

Zaiki, Y., Lim, L. Y., & Wong, T. W. (2022) · International Materials Reviews · doi:10.1080/09506608.2022.2040293 · Cited by 45 · see citing works

Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers

Pan, Z., Tan, Z., Xu, N., Yao, Z., Zheng, C., Shang, J., Xie, L., Xu, J., Wang, J., Jiang, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58910-3 · Cited by 46 · see citing works

Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development

Duan, X., Wang, W., Pan, Q., & Guo, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.730038 · Cited by 41 · see citing works

The insulin and IGF signaling pathway sustains breast cancer stem cells by IRS2/PI3K-mediated regulation of MYC

Lee, J., Lero, M. W., Mercado-Matos, J., Zhu, S., Jo, M., Tocheny, C. E., Morgan, J. S., & Shaw, L. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111759 · Cited by 36 · see citing works

Nutrition and dietary restrictions in cancer prevention

Mishra, A. K., Giuliani, G., & Longo, V. D. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189063 · Cited by 37 · see citing works

The Interlinking Metabolic Association between Type 2 Diabetes Mellitus and Cancer: Molecular Mechanisms and Therapeutic Insights

Asiri, A., Qarni, A. A. A., & Bakillah, A. (2024) · Diagnostics · doi:10.3390/diagnostics14192132 · Cited by 35 · see citing works

Drug‐like sphingolipid SH‐BC‐893 opposes ceramide‐induced mitochondrial fission and corrects diet‐induced obesity

Jayashankar, V., Selwan, E. M., Hancock, S. E., Verlande, A., Goodson, M. O., Eckenstein, K. H., Milinkeviciute, G., Hoover, B., Chen, B., Fleischman, A. G., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013086 · Cited by 31 · see citing works

Assessing the association of diabetes with lung cancer risk

Leiter, A., Charokopos, A., Bailey, S., Gallagher, E. J., Hirsch, F. R., LeRoith, D., & Wisnivesky, J. P. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-601 · Cited by 31 · see citing works

Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics

Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00282-z · Cited by 32 · see citing works

Food processing groups and colorectal cancer risk in Morocco: evidence from a nationally representative case–control study

Kinany, K. E., Huybrechts, I., Hatime, Z., Asri, A. E., Boudouaya, H. A., Deoula, M. M. S., Kampman, E., & Rhazi, K. E. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02820-3 · Cited by 30 · see citing works

Insulin resistance in cancer risk and prognosis

Jacobo-Tovar, E., Medel-Sánchez, A., Durán-Castillo, C., & Guardado‐Mendoza, R. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.006 · Cited by 29 · see citing works

Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress

Zhou, J., Lin, Y., Yang, X., Shen, B., Hao, J., Wang, J., & Wang, J. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00412-x · Cited by 29 · see citing works

Socioeconomic status and lifestyle patterns in the most common cancer types-community-based research

Sandström, N., Johansson, M., Jekunen, A. P., & Andersén, H. (2023) · BMC Public Health · doi:10.1186/s12889-023-16677-6 · Cited by 29 · see citing works

Unmasking BACE1 in aging and age-related diseases

Bao, H., & Shen, Y. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.11.008 · Cited by 28 · see citing works

Insulin resistance and cancer: molecular links and clinical perspectives

Caturano, A., Erul, E., Nilo, R., Nilo, D., Russo, V., Rinaldi, L., Acierno, C., Gemelli, M., Ricotta, R., Sasso, F. C., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05245-8 · Cited by 26 · see citing works

Moringa Oleifera Seed Extract Concomitantly Supplemented with Chemotherapy Worsens Tumor Progression in Mice with Triple Negative Breast Cancer and Obesity

Zunica, E. R. M., Yang, S., Coulter, A. A., White, C. L., Kirwan, J. P., & Gilmore, L. A. (2021) · Nutrients · doi:10.3390/nu13092923 · Cited by 26 · see citing works

A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes

Campbell, T. M., Campbell, E. K., Culakova, E., Blanchard, L., Wixom, N., Guido, J. J., Fetten, J. V., Huston, A. J., Shayne, M., Janelsins, M. C., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07266-1 · Cited by 26 · see citing works

mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy

Saha, S., Fang, X., Green, C. D., & Das, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015078 · Cited by 24 · see citing works

Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells

Vella, V., Giuliano, M., Ferlita, A. L., PELLEGRINO, M. A., Gaudenzi, G., Alaimo, S., Massimino, M., Pulvirenti, A., Dicitore, A., Vigneri, P. G., et al. (2021) · Cells · doi:10.3390/cells10113145 · Cited by 24 · see citing works

Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies

Basu, R., Boguszewski, C. L., & Kopchick, J. J. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae030 · Cited by 25 · see citing works

Associations of metabolic syndrome and metabolically unhealthy obesity with cancer mortality: The Japan Multi-Institutional Collaborative Cohort (J-MICC) study

Tiến, N. V., Arisawa, K., Katsuura‐Kamano, S., Ishizu, M., Nagayoshi, M., Okada, R., Hishida, A., Tamura, T., Hara, M., Tanaka, K., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269550 · Cited by 22 · see citing works

Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trial

Diefenhardt, M., Ludmir, E. B., Hofheinz, R., Ghadimi, M. B., Minsky, B. D., Fleischmann, M., Fokas, E., & Rödel, C. M. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.09.028 · Cited by 20 · see citing works

VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin/IGF signaling

Gao, X. K., Sheng, Z. K., Lu, Y. H., Sun, Y. T., Rao, X. S., Shi, L. J., Cong, X. X., Chen, X., Wu, H. B., Huang, M., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00576-6 · Cited by 20 · see citing works

Effects of Functional and Nutraceutical Foods in the Context of the Mediterranean Diet in Patients Diagnosed with Breast Cancer

Flore, G., Deledda, A., Lombardo, M., Armani, A., & Velluzzi, F. (2023) · Antioxidants · doi:10.3390/antiox12101845 · Cited by 20 · see citing works

Race as a Contributor to Stromal Modulation of Tumor Progression

Kakarla, M., ChallaSivaKanaka, S., Hayward, S. W., & Franco, O. E. (2021) · Cancers · doi:10.3390/cancers13112656 · Cited by 20 · see citing works

Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines

Ambrosio, M. R., Mosca, G., Migliaccio, T., Liguoro, D., Nele, G., Schönauer, F., D’Andrea, F., Liotti, F., Prevete, N., Melillo, R. M., et al. (2022) · Cancers · doi:10.3390/cancers14215421 · Cited by 18 · see citing works

Triglyceride-Glucose Index, Modifiable Lifestyle, and Risk of Colorectal Cancer: A Prospective Analysis of the Korean Genome and Epidemiology Study

Kityo, A., & Lee, S. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00282-w · Cited by 18 · see citing works

Insulin resistance: Risk factors, diagnostic approaches and mathematical models for clinical practice, epidemiological studies, and beyond

Krzymień, J., & Ładyżyński, P. (2023) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2023.12.004 · Cited by 17 · see citing works

Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021

Zhan, Z., Chen, X., Xu, S., Li, Q., Yu, J., Guo, Z., & Chen, B. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03582-4 · Cited by 17 · see citing works

Metabolic and Genetic Association of Vitamin D with Calcium Signaling and Insulin Resistance

Tarfeen, N., Nisa, K. U., Ahmad, M., Waza, A., & Ganai, B. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01105-0 · Cited by 21 · see citing works

MultiCens: Multilayer network centrality measures to uncover molecular mediators of tissue-tissue communication

Kumar, T., Sethuraman, R., Mitra, S., Ravindran, B., & Narayanan, M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011022 · Cited by 18 · see citing works

Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses

Dimou, N. L., Kim, A. E., Flanagan, O., Murphy, N., Díez‐Obrero, V., Shcherbina, A., Aglago, E. K., Bouras, E., Campbell, P. T., Casey, G., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02312-z · Cited by 16 · see citing works

Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration

Park, J. B., Moon, G. H., Cho, A., Kwon, M., Park, J., Yi, E. C., Kim, H., Fukuda, J., Kwak, C. H., Ko, Y., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00729-z · Cited by 16 · see citing works

Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?

Bril, F., & Elbert, A. E. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156066 · Cited by 17 · see citing works

Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases

Harlid, S., Guelpen, B. R. V., Qu, C., Gylling, B., Aglago, E. K., Amitay, E. L., Brenner, H., Buchanan, D. D., Campbell, P. T., Cao, Y., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34015 · Cited by 15 · see citing works

Obesity and Cancer Risk in White and Black Adults: A Prospective Cohort Study

Brown, J. C., Yang, S., Mire, E. F., Wu, X., Miele, L., Ochoa, A. C., Zabaleta, J., & Katzmarzyk, P. T. (2021) · Obesity · doi:10.1002/oby.23163 · Cited by 15 · see citing works

mTORC1 syndrome (TorS): unified paradigm for diabetes/metabolic syndrome

Bar‐Tana, J. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.01.001 · Cited by 16 · see citing works

Interlinking of diabetes mellitus and cancer: An overview

Ahmad, I., Suhail, M., Ahmad, A., Alhosin, M., & Tabrez, S. S. M. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3802 · Cited by 14 · see citing works

Complexity of insulin resistance in early-onset colorectal cancer

Samuel, S. M., Varghese, E., & Büsselberg, D. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.033 · Cited by 13 · see citing works

A prospective investigation of early-onset colorectal cancer risk factors–pooled analysis of three large-scale European cohorts

Laskar, R. S., Murphy, N., Ferrari, P., Brennan, P., Cross, A. J., Guevara, M., Pala, V. M., Smith-Byrne, K., Tjønneland, A. M., Fortner, R. T., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03303-y · Cited by 13 · see citing works

Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown

Mannucci, E., & Dicembrini, I. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01135-0 · Cited by 13 · see citing works

Advancements in the study of glucose metabolism in relation to tumor progression and treatment

Zhao, M., Chen, Y., & Yang, L. (2024) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2024.08.001 · Cited by 13 · see citing works

New Discoveries and Ambiguities of Nrf2 and ATF3 Signaling in Environmental Arsenic-Induced Carcinogenesis

Bi, Z., Fu, Y. S., Wadgaonkar, P., Qiu, Y., Almutairy, B. S., Zhang, W., Seno, A., Thakur, C., & Chen, F. (2021) · Antioxidants · doi:10.3390/antiox11010077 · Cited by 13 · see citing works

Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk

Ma, Z., Wang, S., Liu, S., Yang, W., Hu, J., Lv, L., Qian, Y., & Lu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1653442 · Cited by 16 · see citing works

Multivariate genome-wide analyses of insulin resistance unravel novel loci and therapeutic targets for cardiometabolic health

Ye, C., Dou, C., Liu, D., Kong, L., Chen, M., Xu, M., Xu, Y., Li, M., Zhao, Z., Zheng, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64985-9 · Cited by 13 · see citing works

Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis

Wang, S., Zhang, W. S., Jiang, C. Q., Jin, Y. L., Zhu, T., Zhu, F., & Xu, L. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0383 · Cited by 12 · see citing works

Exercise as a therapeutic intervention for long-lasting and chronic diseases

Febbraio, M. A., & Pedersen, B. K. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.02.017 · Cited by 12 · see citing works

Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms

Wang, L., & Zhang, Z. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4388437 · Cited by 11 · see citing works

Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries

Demarchis, L., Chiloiro, S., Giampietro, A., Marinis, L. D., Bianchi, A., Fleseriu, M., & Pontecorvi, A. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09957-6 · Cited by 11 · see citing works

Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients

Oliveres, H., Pesántez, D., & Maurel, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095019 · Cited by 11 · see citing works

Insulin Analogues with Altered Insulin Receptor Isoform Binding Specificities and Enhanced Aggregation Stabilities

Páníková, T., Mitrová, K., Halamová, T., Mrzílková, K., Pícha, J., Chrudinová, M., Kurochka, A. S., Selicharová, I., Žáková, L., & Jiráček, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01388 · Cited by 11 · see citing works

Genetically proxied impaired GIPR signaling and risk of 6 cancers

Rogers, M., Gill, D., Ahlqvist, E., Robinson, T., Mariosa, D., Johansson, M., Penha, R. C. C., Dossus, L., Gunter, M. J., Moreno, V. R., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106848 · Cited by 10 · see citing works

Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors

Chen, Y., Yamamoto, T., Takahashi, Y., Moro, T., Tajima, T., Sakaguchi, Y., Sakata, N., Yokoyama, A., Hijioka, S., Sada, A., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06123-1 · Cited by 10 · see citing works

Mechanisms Underlying the Rarity of Skeletal Muscle Cancers

Kump, D. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126480 · Cited by 10 · see citing works

Pathological Significance of GLUT-1 Expression in Breast Cancer Cells in Diabetic and Obese Patients: The French Guiana Study

Suteau, V., Bukasa-Kakamba, J., Cenciu, B., Adenis, A. A., Sabbah, N., & Alsibai, K. D. (2022) · Cancers · doi:10.3390/cancers14020437 · Cited by 10 · see citing works

The Impact of Bariatric Surgery on Pancreatic Cancer Risk: a Systematic Review and Meta-Analysis

Fan, H.-D., Mao, Q., Zhang, W., Fang, Q., Zou, Q., & Gong, J. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06570-x · Cited by 10 · see citing works

Insulin resistance: mechanisms and therapeutic interventions

Yu, L., Qian, J., Li, X., Tian, M., Bai, X., Yang, J., Deng, R., Lu, C., He, X., Lü, A., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00408-5 · Cited by 9 · see citing works

Dietary Acid Load and Cancer Risk: A Review of the Uruguayan Experience

Ronco, Á. L., & Storz, M. A. (2023) · Nutrients · doi:10.3390/nu15143098 · Cited by 9 · see citing works

Insulin resistance and hyperinsulinaemia in the development and progression of cancer

Godsland, I. F. (2009) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231 · see citing works

Hyperinsulinaemia and cancer risk: cause and effect?

Kilvert, A., & Fox, C. (2020) · Practical Diabetes · doi:10.1002/pdi.2310 · Cited by 10 · see citing works

Insulin Resistance: The Increased Risk of Cancers

Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 107 · see citing works

A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors

Westley, R., & May, F. E. B. (2013) · International Journal of Endocrinology · doi:10.1155/2013/632461 · Cited by 59 · see citing works

Rethinking the Relationship between Insulin and Cancer

Vigneri, R., Sciacca, L., & Vigneri, P. G. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.05.004 · Cited by 84 · see citing works